With her extensive experience in weight management and compassionate approach, she creates customized treatment plans that address your unique needs
Figure 1 4 Metabolic disorders and IBD The prevalence of metabolic disorders, including DM2 and obesity, is increasingly rising in the IBD population
5 Semaglutide has been compared with the weight-loss medication liraglutide (Saxenda) and was found to be superior, resulting in significantly more weight loss after 68 weeks (mean weight reduction = 15.8% vs
SGLT2 inhibitors are a class of medicines used to treat type 2 diabetes
Regular Exercise: Engage in regular, moderate exercise
If you're planning pregnancy, discontinue treatment at least 2 months beforehand, as these medications remain in your system for extended periods